224 related articles for article (PubMed ID: 11850250)
1. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.
Walochnik J; Duchêne M; Seifert K; Obwaller A; Hottkowitz T; Wiedermann G; Eibl H; Aspöck H
Antimicrob Agents Chemother; 2002 Mar; 46(3):695-701. PubMed ID: 11850250
[TBL] [Abstract][Full Text] [Related]
2. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
Mrva M; Garajová M; Lukáč M; Ondriska F
J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of structural analogues of hexadecylphosphocholine and their antineoplastic, antimicrobial and amoebicidal activity.
Timko L; Fischer-Fodor E; Garajová M; Mrva M; Chereches G; Ondriska F; Bukovský M; Lukáč M; Karlovská J; Kubincová J; Devínsky F
Eur J Med Chem; 2015 Mar; 93():263-73. PubMed ID: 25698517
[TBL] [Abstract][Full Text] [Related]
4. Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba.
Baltaza W; Padzik M; Szaflik JP; Dybicz M; Hendiger E; Chomicz L
Ann Parasitol; 2017; 63(3):167-172. PubMed ID: 29274209
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
6. Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent.
Walochnik J; Obwaller A; Gruber F; Mildner M; Tschachler E; Suchomel M; Duchêne M; Auer H
J Antimicrob Chemother; 2009 Sep; 64(3):539-45. PubMed ID: 19549672
[TBL] [Abstract][Full Text] [Related]
7. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba.
McBride J; Ingram PR; Henriquez FL; Roberts CW
J Clin Microbiol; 2005 Feb; 43(2):629-34. PubMed ID: 15695656
[TBL] [Abstract][Full Text] [Related]
8. Isobenzofuran-1(3H)-one derivatives: Amoebicidal activity and program cell death in Acanthamoeba castellanii Neff.
Rodríguez-Expósito RL; Reyes-Batlle M; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2022 Jun; 150():113062. PubMed ID: 35658232
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphological changes and susceptibility of clinical isolates of Acanthamoeba spp. to heterocyclic alkylphosphocholines.
Garajová M; Mrva M; Timko L; Lukáč M; Ondriska F
Exp Parasitol; 2014 Nov; 145 Suppl():S102-10. PubMed ID: 24882041
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, physicochemical properties and biological activities of novel alkylphosphocholines with foscarnet moiety.
Timko L; Pisárčik M; Mrva M; Garajová M; Juhásová A; Mojžiš J; Mojžišová G; Bukovský M; Devínsky F; Lukáč M
Bioorg Chem; 2020 Nov; 104():104224. PubMed ID: 32892068
[TBL] [Abstract][Full Text] [Related]
11. Amebicidal activity of the essential oils of Lippia spp. (Verbenaceae) against Acanthamoeba polyphaga trophozoites.
Santos IG; Scher R; Rott MB; Menezes LR; Costa EV; Cavalcanti SC; Blank AF; Aguiar Jdos S; da Silva TG; Dolabella SS
Parasitol Res; 2016 Feb; 115(2):535-40. PubMed ID: 26446087
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial effect of auranofin against Acanthamoeba spp.
Loufouma Mbouaka A; Leitsch D; Koehsler M; Walochnik J
Int J Antimicrob Agents; 2021 Nov; 58(5):106425. PubMed ID: 34419578
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
Padzik M; Baltaza W; Szaflik JP; Hendiger E; Dybicz M; Chomicz L
Ann Parasitol; 2018; 64(3):229-233. PubMed ID: 30316219
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Sharma G; Kalra SK; Tejan N; Ghoshal U
Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of in vitro effects of selected physical and chemical agents on detected in Poland Acanthamoeba strains – factors of increasing threats for public health.
Baltaza W; Padzik M; Szaflik JP; Perkowski K; Dybicz M; Chomicz L
Ann Parasitol; 2019; 65(1):19-25. PubMed ID: 31095904
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.
Polat ZA; Karakus G
Parasitol Res; 2013 Feb; 112(2):529-33. PubMed ID: 23052789
[TBL] [Abstract][Full Text] [Related]
18. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
[TBL] [Abstract][Full Text] [Related]
19. Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Sifaoui I; Reyes-Batlle M; Fouque E; Osuna A; Valladares B; Piñero JE; Héchard Y; Maciver SK; Lorenzo-Morales J
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320723
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of isavuconazole against three species of Acanthamoeba.
Brunet K; Eestermans R; Rodier MH; Cateau E
J Fr Ophtalmol; 2020 Apr; 43(4):330-333. PubMed ID: 32151474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
